MicroRNA-376b-3p can target RGS1 mRNA to inhibit the development of osteosarcoma [30], and RGS1 expression desensitizes G-protein-coupled receptor signaling and is associated with poor prognosis in multiple myeloma [31]. Here, RGS1 is linked to plasma cell myeloma.